AKT1 and chronic obstructive pulmonary disease: Macrolides may reduce lung inflammation in COPD by modulating the PI3K/Akt pathway, such as erythromycin, which enhances corticosteroid sensitivity by inhibiting the activity of the PI3K/Akt pathway (Miao et al., 2015; Sun et al., 2015).